News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzo Biochem (ENZ) Presents New AmpiProbe™ Nucleic Acid Amplification Platform Details at ESCMID London Meeting



4/2/2012 10:34:20 AM

EW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid amplification and detection assays, at the annual meeting in London of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES